Shibani Ratnayake
Papers
1
Total Citations
17
H-Index
1
About
Dr. Shibani Ratnayake is a pioneering researcher at the intersection of robotics, biomanufacturing, and cell therapy. Her work focuses on revolutionizing the production of Advanced Therapeutic Medicinal Products (ATMPs) by automating the complex, manual processes that currently limit their scalability and clinical accessibility. Her landmark 2022 paper, “Needle to needle robot-assisted manufacture of cell therapy products,” which has garnered 17 citations, introduces a fully integrated robotic platform capable of handling the entire cell therapy manufacturing workflow—from initial cell processing to final product formulation. This breakthrough addresses a critical bottleneck in the field: the costly, high-risk, and labor-intensive nature of Good Manufacturing Practice (GMP) cell expansion. By demonstrating a closed, automated system that maintains cell quality and sterility, Dr. Ratnayake’s work provides a scalable solution to produce large volumes of clinically-compliant cells, significantly reducing production costs and risks. Her contributions are essential for translating promising cell-based therapies from the lab to widespread patient use, positioning her as a key innovator in next-generation biomanufacturing.
Research Focus
Key Achievements
Top Papers
- 1